Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial

This publication has 46 references indexed in Scilit:

• New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
  Journal of Neuro-Oncology, 2013
• Corticotroph adenoma in the dog: Pathogenesis and new therapeutic possibilities
  Research in Veterinary Science, 2010
• Cushing’s disease in dogs: Cabergoline treatment
  Research in Veterinary Science, 2008
• Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing’s Disease
  Endocrinology, 2008
• Pituitary-targeted medical therapy of Cushing's disease
  Expert Opinion on Investigational Drugs, 2008
• Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane
  Domestic Animal Endocrinology, 2006
• New Aspects in the Diagnosis and Treatment of Cushing Disease
  2006
• Treatment with L-deprenyl prolongs life in elderly dogs
  Life Sciences, 1997
• Effects of bromocriptine on corticotrophin, melanotrophin and corticosteroid secretion in dogs with pituitary-dependent hyperadrenocorticism
  Journal of Endocrinology, 1988
• An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism
  1988